Reaction

Restrictive Pulmonary Disease reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,153 reports · 40 co-occurring drugs

As of the last recalculation, Restrictive Pulmonary Disease appears in 1,153 FAERS reports alongside 40 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 239.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	156	239.0	241.7
Fluticasone Furoate	47	73.0	73.3
Ipratropium Bromide	88	48.1	48.2
Mepolizumab	98	38.8	38.9
Rosuvastatin Calcium	56	37.7	37.7
Fluticasone Propionate And Salmeterol Xinafoate	112	37.2	37.2
Montelukast Sodium	205	36.7	36.8
Omalizumab	141	33.9	33.9
Fluticasone Furoate And Vilanterol Trifenatate	51	26.7	26.8
Tiotropium Bromide	173	26.6	26.7
Cetirizine Hydrochloride Allergy	39	24.0	24.1
Cetirizine Hydrochloride Tablets	39	24.0	24.1
Ezetimibe	82	21.2	21.2
Cetirizine	82	20.5	20.5
Doxepin Hydrochloride	14	20.2	20.3
Cetiirizine	45	19.9	19.9
Doxepin	11	19.8	19.8
Cefuroxime	12	19.1	19.2
Budesonide And Formoterol Fumarate Dihydrate	92	18.5	18.5
Umeclidinium	9	18.3	18.3
Albuterol Sulfate	218	16.1	16.1
Bleomycin Sulfate	9	15.8	15.9
Acetylcysteine	8	15.4	15.4
Quetiapine Fumarate	24	15.0	15.0
Ganciclovir	8	14.2	14.2
Pirfenidone	31	14.1	14.1
Fluticasone Propionate Nasal	23	14.0	14.0
Ganciclovir Sodium	8	13.7	13.7
Amiodarone Hydrochloride	8	13.0	13.0
Epinephrine	44	12.6	12.6
Imatinib	11	11.4	11.4
Tiotropium Bromide Inhalation Spray	7	11.3	11.3
Everolimus Tablets	10	10.9	10.9
Dexlansoprazole	22	9.7	9.7
Nintedanib	14	8.1	8.1
Pemetrexed	9	7.6	7.6
Ifosfamide	9	7.6	7.6
Brentuximab Vedotin	4	7.1	7.1
Ranitidine Hydrochloride	13	4.4	4.4
Palivizumab	3	3.5	3.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.